Q1 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-14 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.430 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
ALXO | ALX Oncology Holdings | 59.80 | 0.00 | 0% | 2.4B |
You can purchase shares of ALX Oncology Holdings (NASDAQ: ALXO) through any online brokerage.
Other companies in ALX Oncology Holdings’s space includes: Burning Rock Biotech (NASDAQ:BNR), Karuna Therapeutics (NASDAQ:KRTX) and FibroGen (NASDAQ:FGEN).
The latest price target for ALX Oncology Holdings (NASDAQ: ALXO) was reported by UBS on 2021-04-06. The analyst firm set a price target for 96.00 expecting ALXO to rise to within 12 months (a possible 60.54% upside). 7 analyst firms have reported ratings in the last year.
The stock price for ALX Oncology Holdings (NASDAQ: ALXO) is $59.8 last updated Today at 8:00:01 PM.
There are no upcoming dividends for ALX Oncology Holdings.
There is no upcoming split for ALX Oncology Holdings.